Adaptix RCT Evaluating Adaptix™ Versus PEEK Cages
Key facts
- Who runs it
- Ohio State University
- Where
- Columbus, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 100 people, planned
- Started
- 19 Nov 2021
- Ended
- 1 Apr 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Medtronic Adaptix™ titanium implants
- Medtronic CAPSTONE® PEEK cage
- Record updated
- 25 February 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Subject is scheduled to undergo combined interbody and posterolateral spinal fusion surgery using either the Medtronic Adaptix™ titanium cage or Medtronic CAPSTONE® PEEK cage in conjunction with a 50:50 mixture of local autograft and GRAFTON™ DBM DBF, and supplementation with a pedicle screw system
- Subject must be over the age of 18 years old
- Subject has been unresponsive to conservative care for a minimum of 6 months
- The subject must in the investigator's opinion, be psychosocially, mentally, and physically able to fully comply with this protocol including the required follow-up visits, the filling out of required forms, and have the ability to understand and give written informed consent
Who cannot take part
- Subjects with previous lumbar arthrodesis surgery
- Subject is currently involved in another investigational drug or device study that could confound study data
- Subject has a history (present or past) of substance abuse (recreational drugs, prescription drugs or alcohol) that in the investigator's opinion may interfere with protocol assessments and/or with the subject's ability to complete the protocol required follow-up
- Subject is involved in or planning to engage in litigation or receiving Worker's Compensation related to neck or back pain
- Subject has an open wound local to the operative area, or rapid joint disease, bone absorption, or osteoporosis
- Subject has a condition requiring medications that may interfere with bone or soft tissue healing (i.e., oral or parenteral glucocorticoids, immunosuppressives, methotrexate, etc.)
- Subject has an active local or systemic infection
- Subject is allergic to antibiotics (gentamicin) or processing solutions found in GRAFTON™
- Subject has any medical condition or extenuating circumstance that, in the opinion of the investigator, would preclude participation in the study
- Subjects requiring additional bone grafting materials other than local autograft bone or GRAFTON™ DBM DBF
- Subject has inadequate tissue coverage over the operative site
- Subject has a metal sensitivity/foreign body sensitivity
- Subject is morbidly obese, defined as a body mass index (BMI) greater than 45
- Subjects who are pregnant or plan to become pregnant in the next 12 months or who are lactating
- Subject is a prisoner
Where in United States
- The Ohio State University Wexner Medical Center Neurological SurgeryColumbus, United States
About the trial
What the trial wants to find out
The purpose of this randomized controlled trial is to assess and compare radiographic and clinical outcomes in patients who are to undergo combined interbody/posterolateral lumbar fusion procedures, supplemented with pedicle screw instrumentation, using one of the following interbody cages; the Medtronic Adaptix™ cage with roughened micro and nano-textured titanium surfaces or the CAPSTONE® poly-ether-ether-ketone cage.
The 2 groups in the trial
- Medtronic Adaptix™ titanium implantsTreatment being tested
This arm will use Medtronic Adaptix™ titanium implants supplemented with a pedicle screw system. Both cages will be used in conjunction with a 50:50 mixture of autograft: allograft using milled local autograft bone and GRAFTON™ DBM DBF (no iliac crest autograft will be utilized).
- Medtronic CAPSTONE® PEEK cageExisting treatment, for comparison
This arm will use Medtronic CAPSTONE® PEEK cage supplemented with a pedicle screw system. Both cages will be used in conjunction with a 50:50 mixture of autograft: allograft using milled local autograft bone and GRAFTON™ DBM DBF (no iliac crest autograft will be utilized).
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Lumbar Fusion With Micro and Nano-textured Titanium Interbody Cages - A Single-Blinded Randomized Controlled Trial Evaluating Adaptix™ Versus PEEK Cages
- Record updated
- 25 February 2026